Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
Status:
Unknown status
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this 1-year study is to evaluate the efficacy and safety of a new
contraceptive vaginal ring (CVR) delivering low doses of Nestorone (NES), a new,
nonandrogenic progestin, and ethinyl estradiol (EE), an estrogen used in oral
contraceptives. The CVR, which is made of silicone rubber, is designed to be used for 1 year
(13 menstrual cycles) before replacement is required.
Phase:
Phase 3
Details
Lead Sponsor:
Population Council
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) United States Agency for International Development (USAID) World Health Organization
Treatments:
Contraceptive Agents Estradiol Ethinyl Estradiol ST 1435